MedPath

Inspiratory Muscle Training for Patients With Chronic Obstructive Pulmonary Disorder

Not Applicable
Completed
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
Device: Threshold IMT Philips Respironics
Registration Number
NCT02673242
Lead Sponsor
Sykehuset Innlandet HF
Brief Summary

This study is a randomized controlled trial with the aim of evaluating the effect of homebased inspiratory muscle training (IMT) for patients with COPD in Norway. The intervention group will train with threshold IMT for 6 weeks. The control group will not participate in any other training method or sham. Evaluation parameters are maximal inspiratory pressure, six minute walk test, COPD assessment test, modified Medical research council dyspnea scale and spirometry.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
3
Inclusion Criteria
  • COPD grade III-IV,
  • Inhabitant of Hedmark (Løten, Våler, Åsnes, Hamar, Elverum)
Exclusion Criteria
  • Undergoing exercise based physical therapy treatment,
  • not able to do IMT physically or mentally

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InterventionThreshold IMT Philips RespironicsInspiratory muscle training
Primary Outcome Measures
NameTimeMethod
Maximal inspiratory pressure6 weeks
Secondary Outcome Measures
NameTimeMethod
COPD Assessment Test6 weeks
Six minute walk test6 weeks
Modified Medical Research Council Dyspnea Scale6 weeks
Spirometry6 weeks

Trial Locations

Locations (1)

Sykehuset Innlandet Hospital Trust

🇳🇴

Elverum, Norway

© Copyright 2025. All Rights Reserved by MedPath